
Eli Lilly 4E Therapeutics Acquisition Aims For Chronic Pain Treatments
Pharmaceutical giant Eli Lilly and Company is continuing its acquisition spree with the purchase of Austin-based biotech company 4E Therapeutics.
Pharmaceutical giant Eli Lilly and Company is continuing its acquisition spree with the purchase of Austin-based biotech company 4E Therapeutics. The Eli …
New World screwworm, a flesh-eating parasite eradicated from the United States decades ago, has returned, that too in the nation’s largest livestock-producing …
The Nara Organics Baby Formula recall has been announced across three states after U.S. health officials linked the product to a multistate …
The UK government announced a one-off emergency MenB vaccination campaign to combat rising cases of meningococcal disease. In this urgent rollout of …
In a new update for the obesity market, Britain has authorized an oral version of Novo Nordisk’s blockbuster weight-loss medicine Wegovy. The …
The U.S. Food and Drug Administration (FDA) has announced that bemotrizinol has been added to the list of permitted over-the-counter (OTC) sunscreen …
Thousands of men across England will soon benefit from new NHS prostate cancer radiotherapy, a major advancement that could significantly reduce treatment …
In one of the largest biotechnology deals of 2026, the UK’s GSK announced it will acquire Nuvalent, a US-based clinical-stage biotechnology company, …
Incyte Corporation is set to purchase Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, strengthening its position in hematology. The Incyte …
The recent findings from the Survodutide weight-loss drug trial by Boehringer Ingelheim were released recently. Licensed from Denmark’s Zealand Pharma, the experimental …
A major breakthrough in women’s cancer care has arrived in England after the approval of the new ovarian cancer drug Elahere (mirvetuximab …
In a scientific breakthrough, an AI-designed vaccine for viruses has successfully completed its first human clinical trial, marking a significant step toward …

Pharmaceutical giant Eli Lilly and Company is continuing its acquisition spree with the purchase of Austin-based biotech company 4E Therapeutics.

New World screwworm, a flesh-eating parasite eradicated from the United States decades ago, has returned, that too in the nation’s

The Nara Organics Baby Formula recall has been announced across three states after U.S. health officials linked the product to

The UK government announced a one-off emergency MenB vaccination campaign to combat rising cases of meningococcal disease. In this urgent

In a new update for the obesity market, Britain has authorized an oral version of Novo Nordisk’s blockbuster weight-loss medicine

The U.S. Food and Drug Administration (FDA) has announced that bemotrizinol has been added to the list of permitted over-the-counter

Thousands of men across England will soon benefit from new NHS prostate cancer radiotherapy, a major advancement that could significantly

In one of the largest biotechnology deals of 2026, the UK’s GSK announced it will acquire Nuvalent, a US-based clinical-stage

Incyte Corporation is set to purchase Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, strengthening its position in hematology.

The recent findings from the Survodutide weight-loss drug trial by Boehringer Ingelheim were released recently. Licensed from Denmark’s Zealand Pharma,

A major breakthrough in women’s cancer care has arrived in England after the approval of the new ovarian cancer drug

In a scientific breakthrough, an AI-designed vaccine for viruses has successfully completed its first human clinical trial, marking a significant